Hepatic steatosis is associated with increased production of interleukin-6 and other proinflammatory cytokines by hepatozytes and nonperynchymal cells, including Kupfer cells.[19–22] These increased cytokine expression is likely to play a key role in the progression of NAFLD and cardiovascular disease as well. Here, IL6 is linked to metabolic dysfunction-associated steatotic liver disease.